World's Best Scientists 2026 revealed!
Journal of Hepatocellular Carcinoma
H-index 18

Journal of Hepatocellular Carcinoma

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1548 69 59 16

Additional Metrics

Number of Best Scientists*: 105
Documents by Best Scientists*: 92
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 10
SCIMAGO SJR: 0.734
Impact Factor: 3.4

Overview

Top Research Topics at Journal of Hepatocellular Carcinoma?

Journal of Hepatocellular Carcinoma mainly deals with areas of study such as Hepatocellular carcinoma, Internal medicine, Oncology, Gastroenterology and Sorafenib. Journal of Hepatocellular Carcinoma explores issues in Hepatocellular carcinoma which can be linked to other research areas like Cancer, Cirrhosis and Liver transplantation. Topics in Cirrhosis were tackled in line with various other fields like Fibrosis, Nonalcoholic fatty liver disease, Hepatitis C and Magnetic resonance imaging.

Journal of Hepatocellular Carcinoma focuses on Internal medicine but sometimes tackles the closely related topic of Hepatitis C virus which is concerned with Hepatitis B virus. While work presented in the journal provided substantial information on Oncology, it also covered topics in Pembrolizumab, Atezolizumab, Immunotherapy and Alpha-fetoprotein. While the journal focused on Gastroenterology, it was also able to explore topics like Hepatitis B, Adverse effect, Retrospective cohort study and Confidence interval.

The concepts on Sorafenib presented in the journal can also apply to other research fields, including Randomized controlled trial, Cabozantinib, Radiation therapy and Clinical trial. Concepts in Stage (cooking), as well as related topics in Disease, are covered in the Liver cancer research presented in Journal of Hepatocellular Carcinoma. The journal holds forums on Cancer research that merges themes from other disciplines such as Carcinogenesis, Downregulation and upregulation, Immunology, Signal transduction and In vivo.

  • Hepatocellular carcinoma (82.81%)
  • Internal medicine (55.66%)
  • Oncology (29.41%)

What are the most cited papers published in the journal?

  • Hepatocellular carcinoma: a review (480 citations)
  • Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. (78 citations)
  • Hepatocellular carcinoma: epidemiology and risk factors. (59 citations)

Research areas of the most cited articles at Journal of Hepatocellular Carcinoma:

The main points discussed in the most cited articles deal with Hepatocellular carcinoma, Internal medicine, Oncology, Sorafenib and Chronic liver disease. The published articles emphasize research on Hepatocellular carcinoma, which includes concerns such as HCCS. The most cited articles dive deep in exploring the relationship between the study of Internal medicine and Gastroenterology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Gene

The previous edition focused in particular on these issues:

Journal of Hepatocellular Carcinoma aims to foster the development of research in Hepatocellular carcinoma, Internal medicine, Oncology, Gastroenterology and Cancer research. Hepatocellular carcinoma research is the primary subject tackled in it with a focus on Liver cancer. Journal of Hepatocellular Carcinoma covers various topics on Internal medicine such as Sorafenib, Proportional hazards model, Cirrhosis, Hazard ratio and Lenvatinib.

The journal deals with Oncology in conjunction with other fields like

  • Atezolizumab that connect with fields like Bevacizumab,
  • Biomarker (medicine) most often made with reference to Immunotherapy.. The Gastroenterology research presented in it explores the relationship between Confidence interval and the closely related topic of Nuclear medicine. The journal tackles studies in Metastasis and the interrelated subject of Cell growth to gain insights into Cancer research.

The most cited articles from the last journal are:

  • Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options. (5 citations)
  • NAFLD-Associated HCC: Progress and Opportunities. (4 citations)
  • Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Hepatocellular Carcinoma (based on the number of publications) are:

  • Ahmed Kaseb (15 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Janio Szklaruk (5 papers) absent at the last edition,
  • Do Young Kim (5 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Armeen Mahvash (4 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Khaled M. Elsayes (4 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Hepatocellular Carcinoma (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (25 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Sun Yat-sen University (15 papers) published 12 papers at the last edition, 9 more than at the previous edition,
  • Fudan University (10 papers) published 8 papers at the last edition, 6 more than at the previous edition,
  • Southern Medical University (9 papers) published 8 papers at the last edition, 7 more than at the previous edition,
  • Peking Union Medical College (7 papers) published 6 papers at the last edition, 5 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.19% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 43.96% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.29% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.68% of all publications and 23.08% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Hepatocellular Carcinoma Research

While the Journal of Hepatocellular Carcinoma provides significant insights into various research topics in the field, it also presents potential career opportunities for students and professionals interested in hepatocellular carcinoma research. These individuals may consider pursuing advanced degrees in fields such as oncology, internal medicine, or gastroenterology. Additionally, positions are available in both research institutions and the healthcare industry that directly deal with hepatocellular carcinoma. For instance, one such option could be pursuing a career path as a nurse practitioner, specializing in oncology. Nurse practitioners play a vital role in cancer treatment plans, which includes hepatocellular carcinoma in their array of study and research. The career requirements and studies needed for this route can be quite rigorous; therefore, thorough preparation is essential. One can find detailed information on the necessary preparations and education, including a comprehensive list of nurse practitioner program requirements, on our dedicated page regarding {anchor}nurse practitioner program requirements in California. Whether you aim to contribute to the field via research or direct patient care, understanding hepatocellular carcinoma's complexities can open various career options and opportunities to make significant contributions to the broader healthcare landscape and patient lives.

Top Publications

  • Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways.

    Mahshid Deldar Abad Paskeh;Sepideh Mirzaei;Milad Ashrafizadeh;Ali Zarrabi

    (2021)
    92 Citations
  • Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions.

    Francesca Fornari;Catia Giovannini;Fabio Piscaglia;Laura Gramantieri

    (2021)
    44 Citations
  • NAFLD-Associated HCC: Progress and Opportunities.

    Daniel Geh;Quentin M Anstee;Helen L Reeves;Helen L Reeves

    (2021)
    44 Citations
  • Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

    (2021)
    33 Citations
  • Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

    Brian De;Sweet Ping Ng;Amy Y Liu;Santiago Avila

    (2021)
    31 Citations
  • Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma.

    Guilherme Moura Cunha;Victoria Chernyak;Kathryn J Fowler;Claude B Sirlin

    (2021)
    28 Citations
  • Neoadjuvant Immunotherapy for Hepatocellular Carcinoma

    (2022)
    27 Citations
  • Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.

    Mihir Gandhi;Wen-Huan Ling;Chien-Hung Chen;Joon Hyeok Lee

    (2021)
    25 Citations
  • Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC.

    Alessandro Granito;Sara Marinelli;Antonella Forgione;Matteo Renzulli

    (2021)
    24 Citations
  • Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

    (2022)
    22 Citations

Related Online Degrees & Career Pathways

For those interested in broadening their expertise beyond traditional medical education, several online degree options offer valuable pathways. An online PhD in healthcare management prepares students for leadership roles in healthcare organizations, focusing on policy, administration, and systems improvement.

Pharmacy is another critical area within healthcare, and pursuing an online PharmD can equip aspiring pharmacists with the knowledge and credentials needed to impact patient care and medication management.

Understanding human movement and physical fitness is essential for careers in rehabilitation and preventative care. An online bachelor's degree in exercise science opens doors to roles in fitness training, wellness coaching, and rehabilitation support.

Similarly, an online kinesiology degree delves into biomechanics, physiology, and motor skills, preparing graduates for careers in clinical therapy, sports science, and occupational health.

These online programs provide flexible learning options that complement medical studies or serve as standalone career development paths in the healthcare sector.

Best Scientists Contributing to This Journal